In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.

     

Tags: BreastCancer

  • Dr. Adam Bass co-authored a study that developed a molecular classification that divides gastric cancer into four major genomic subtypes

Tags: BasicResearch

  • Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.

Tags: OvarianCancer

  • Becker's Hospital Review named Dana-Farber/Brigham and Women's Cancer Center to the 2014 edition of "100 Hospitals and Health Systems With Great Oncology Programs."

Tags: Honors

  • The U.S. News and World Report Best Hospitals Guide has ranked Dana-Farber/Brigham and Women's Cancer Center the highest in New England for cancer care for the 14th straight year and fourth overall in the country.

Tags: Featured, Honors

  • An editorial written by physicians at Dana-Farber supports a study showing there is no compelling evidence to justify using testosterone suppression therapy on men with early-stage prostate cancer.

Tags: ProstateCancer

  • Dr. Ian E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine significantly prolonged progression-free survival in patients with progressive HER2-positive advanced breast cancer.

Tags: BreastCancer

  • Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Tags: BreastCancer

  • Dr. Matthew Meyerson led a genomic study of lung cancer which has provided information that could help scientists devise new treatments.

Tags: Genomics

  • Dr. Paul L. Nguyen led a study showing prostate cancer patients with health insurance are less likely to have metastatic disease or die from the cancer than those without health insurance.

Tags: ProstateCancer

Showing 1-10 of 414 items